SEC Form 4 · accession 0000921895-16-005632
Enveric Biosciences, Inc. · ENVB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Srinidhi Devanur
Officer — Exec. Vice Chairman · Director · 10% Owner
Period of report
Sep 1, 2016
Accepted (ET)
Sep 6, 2016 · 4:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000890821
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Sep 1, 2016 | J | 299,250 | — | A | 6,276,375 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents shares of Common Stock issued to the Reporting Person in connection with the completion of the Issuer's acquisition of Ameri Consulting Service Private Limited on July 1, 2016, for aggregate consideration consisting of (i) $1.00 and (ii) the consideration furnished by the Issuer to the Reporting Person and Giri Devanur and their affiliates pursuant to that certain Agreement of Merger and Plan of Reorganization, dated as of May 26, 2015, as disclosed in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on May 26, 2015.